“All three sets of data will be included with results from the US Early Feasibility Study (EFS), to support Anteris’ application for premarket approval, required to market DurAVRTM THV commercially in the United States.”
I think there is more to this statement from the quarterly, perhaps a heads up from the FDA to put in this application for premarket approval.
- Forums
- ASX - By Stock
- Ann: DurAVR first successful implantation Valve-in-Valve
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$6.00

“All three sets of data will be included with results from the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.00 |
Change
0.000(0.00%) |
Mkt cap ! $92.99M |
Open | High | Low | Value | Volume |
$6.00 | $6.06 | $6.00 | $12.63K | 2.093K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83 | $6.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.09 | 1690 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83 | 6.000 |
2 | 342 | 5.860 |
2 | 625 | 5.850 |
1 | 857 | 5.830 |
1 | 344 | 5.800 |
Price($) | Vol. | No. |
---|---|---|
6.090 | 1690 | 1 |
6.100 | 927 | 2 |
6.140 | 1490 | 1 |
6.150 | 218 | 1 |
6.160 | 92 | 1 |
Last trade - 11.30am 24/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |